Authors
Loading...
Randomized trial examines NOD2’s role in recognizing muramyl dipeptide, suggesting implications for Crohn's disease and vaccine development.
Inohara et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: